LONG-TERM ORAL CIPROFLOXACIN IN THE TREATMENT OF PROSTHETIC VALVE ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA

---

UZUN O., AKALIN H., ÜNAL S., DEMIRCIN M., YORGANCIOGLU A., UGURLU B.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, vol.24, no.6, pp.797-800, 1992 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 24 Issue: 6
• Publication Date: 1992
• Doi Number: 10.3109/00365549209062467
• Journal Name: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.797-800
• Dokuz Eylül University Affiliated: No

Abstract

Prosthetic valve endocarditis caused by Pseudomonas aeruginosa is refractory to medical treatment alone and early valve replacement is necessary. We describe a 40-year-old patient in whom endocarditis developed in the early postoperative period, and reoperation was not considered feasible. Ciprofloxacin was administered orally in order to suppress bacteremia for 36 months. Long-term oral ciprofloxacin may provide an opportunity in the treatment of prosthetic valve endocarditis caused by Ps. aeruginosa in patients who are unfavorable candidates for reoperation.